Log In
BCIQ
Print this Print this
 

Immudia-HemSp

  Manage Alerts
Collapse Summary General Information
Company Fujirebio Inc.
DescriptionReverse passive hemaagglutination test for detection of fecal occult blood (FOB)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationHematology, Diagnostic
Indication DetailsDetect fecal occult blood (FOB)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today